Tissue Engineered Heart Valve Market 2028 Types, Applications | The Insight Partners

report image

Tissue Engineered Heart Valve Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Types ( Transcatheter Heart Valves, Tissue Heart Valves, Mechanical Heart Valves ); Applications ( Heart Surgery, Cardiovascular Disease, Others )

Report Code: TIPRE00010725 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Tissue-engineered heart valves are constructed to design replacement heart valves (most often from decellularized tissues or polymer scaffolds) as well as to generate models of valve disease. Tissue-engineered valve replacements strive to overcome the limitations of mechanical and bioprosthetic valves, because they are living tissues capable of active remodeling and self-repair. Several tissue-engineered valve replacements have displayed promising results in recent large-animal trials. Also, tissue-engineered disease models provide a scalable platform for investigating the pathobiology of valvular diseases like aortic stenosis.


The tissue engineered heart valve market is anticipated to grow due to increasing incidences and awareness of cardiovascular diseases. Moreover, changing lifestyle and increasing technological advancements in the medical devices industry is expected to boost the growth of the market in the forecast period.


The "Tissue Engineered Heart Valve Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of tissue engineered heart valve market with detailed market segmentation by type and application. The tissue engineered heart valve market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in tissue engineered heart valve market and offers key trends and opportunities in the market.


The tissue engineered heart valve market is segmented on the basis of product types and applications. Based on type the market is segmented as transcatheter heart valves, tissue heart valves and mechanical heart valves. On the basis of application, the market is categorized as heart surgery, cardiovascular disease and others.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the tissue engineered heart valve market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The tissue engineered heart valve market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting tissue engineered heart valve market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the tissue engineered heart valve market in these regions.

Get more information on this report :


The report covers key developments in the tissue engineered heart valve market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from tissue engineered heart valve market are anticipated to have lucrative growth opportunities in the future with the rising demand for tissue engineered heart valve in the global market. Below mentioned is the list of few companies engaged in the tissue engineered heart valve market.

The report also includes the profiles of key players in tissue engineered heart valve market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Boston Scientific
  •   Colibri Heart Valve
  •   CryoLife, Inc.
  •   Edwards Lifesciences Corporation
  •   Lepu Medical Technology
  •   LivaNova PLC
  •   Medtronic Inc.
  •   St. Jude Medical
  •   Symetis SA
  •   TTK Healthcare Limited

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Boston Scientific
2. Colibri Heart Valve
3. CryoLife, Inc.
4. Edwards Lifesciences Corporation
5. Lepu Medical Technology
6. LivaNova PLC
7. Medtronic Inc.
8. St. Jude Medical
9. Symetis SA
10. TTK Healthcare Limited
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount